Table 2.
Association between VTE prophylaxis use and in-hospital outcomes
| Unadjusted | Adjusted | |||||
|---|---|---|---|---|---|---|
| OR (95% CI) | P-value | OR (95% CI) | P-value | |||
| In-hospital Mortality | No | Yes | ||||
| No prophylaxis | 889 (99.2%) | 7 (0.8%) | 1.00 | 0.65 | 1.00 | 0.006 |
| Prophylaxis | 3771 (99.3%) | 26 (0.7%) | 0.81 (0.33, 1.99) | 0.21 (0.07, 0.63) | ||
| Non-fatal VTE Event* | No | Yes | ||||
| No prophylaxis | 353 (99.7%) | 1 (0.3%) | 1.00 | 0.010 | 1.00 | 0.07 |
| Prophylaxis | 1984 (96.6 %) | 70 (3.4%) | 13.75 (1.87, 101.32) | 6.73 (0.84, 54.08) | ||
*For patients with International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Australian Modification diagnosis codes accompanying their admissions data
CI confidence interval, OR odds ratio, VTE venous thromboembolism